Advances in blood biomarkers for Alzheimer disease (AD): A review

  • Published on 07/10/2024
  •  Reading time: 4 min.

Araya Dimtsu Assfaw , Suzanne E Schindler , John C Morris

Department of Neurology, Knight Alzheimer Disease Research Center (Knight ADRC) Washington University School of Medicine St. Louis Missouri USA


Alzheimer disease (AD) and Alzheimer Disease and Related Dementias (AD/ADRD) are growing public health challenges globally affecting millions of older adults, necessitating concerted efforts to advance our understanding and management of these conditions. AD is a progressive neurodegenerative disorder characterized pathologically by amyloid plaques and tau neurofibrillary tangles that are the primary cause of dementia in older individuals. Early and accurate diagnosis of AD dementia...


To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Neurology

Receive our newsletter to stay up to date with the latest news in Neurology